Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3–4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination

Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3–4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination

Background: Several countries have authorized a booster vaccine campaign to combat the spread of COVID-19. Data on persistence of booster vaccine‐induced immunity against new Omicron subvariants are still limited. Therefore, our study aimed to determine the serological immune response of COVID-19 bo...

Full description

Bibliographic Details
Main Authors: Suvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong, Jira Chansaenroj, Chompoonut Auphimai, Pornjarim Nilyanimit, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Donchida Srimuan, Thaksaporn Thatsanathorn, Sirapa Klinfueng, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Juthathip Mongkolsapaya, Sittisak Honsawek, Yong Poovorawan
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Heliyon
Subjects:
COVID-19 vaccine
Durability
CoronaVac
Heterologous booster
Neutralizing antibody
Omicron
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023111005

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023111005

Similar Items